The association between ACE polymorphism and risk of colorectal cancer in a Chinese population

Clinical Biochemistry

Volumn 44, Issue 14-15, 2011, Pages 1223-1226

  Liu, Song Yan ^a   Sima, Xiutian ^b   Wang, Chun Hui ^c   Gao, Ming ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Jilin Province Hospital   (China)

Author keywords

ACE; Colorectal cancer; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HETEROZYGOTE DETECTION; HUMAN; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 80052923734     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.07.016     Document Type: Article

References (51)

1. Abali H., Gullu I.H., Engin H., et al. Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Med Hypotheses 2002, 59:344-348.
2. Yoshiji H., Kuriyama S., Fukui H. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol 2002, 23:348-356.
3. Murphey L.J., Gainer J.V., Vaughan D.E., et al. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000, 102:829-832.
4. Deshayes F. Nahmias C Angiotensin receptors: a new role in cancer?. Trends Endocrinol Metab 2005, 16:293-299.
5. Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis?. Oncogene 2004, 23:317-329.
6. Carl-McGrath S., Lendeckel U., Ebert M., et al. The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer. Int J Oncol 2004, 25:1223-1232.
7. Fujita M., Hayashi I., Yamashina S., et al. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 2002, 294:441-447.
8. Volpert O.V., Ward W.F., Lingen M.W., et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996, 98:671-679.
9. Yasumaru M., Tsuji S., Tsujii M., et al. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Cancer Res 2003, 63:6726-6734.
10. Yoshiji H., Kuriyama S., Kawata M., et al. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res 2001, 7:1073-1078.
11. Yoshiji H., Yoshii J., Ikenaka Y., et al. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells. Int J Oncol 2002, 20:1227-1231.
12. Kedika R., Patel M., Pena Sahdala H.N., et al. Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps. J Clin Gastroenterol 2011, 45:e12-e16.
13. Lever A.F., Hole D.J., Gillis C.R., et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?. Lancet 1998, 352:179-184.
14. Rigat B., Hubert C., Alhenc-Gelas F., et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
15. Nakai K., Itoh C., Miura Y., et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994, 90:2199-2202.
16. Winkelmann B.R., Nauck M., Klein B., et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 1996, 125:19-25.
17. Yaren A., Turgut S., Kursunluoglu R., et al. Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients. Tohoku J Exp Med 2006, 210:109-116.
18. Yaren A., Turgut S., Kursunluoglu R., et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with breast cancer and effects on prognostic factors. J Investig Med 2007, 55:255-261.
19. Yuan J.M., Koh W.P., Sun C.L., et al. Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005, 26:1389-1394.
20. Koh W.P., Yuan J.M., Sun C.L., et al. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 2003, 63:573-578.
21. Haiman C.A., Henderson S.O., Bretsky P., et al. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 2003, 63:6984-6987.
22. Alves Correa S.A., Ribeiro de Noronha S.M., Nogueira-de-Souza N.C., et al. Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J Renin Angiotensin Aldosterone Syst 2009, 10:51-58.
23. Koh W.P., Yuan J.M., Van Den Berg D., et al. Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005, 26:459-464.
24. Gonzalez-Zuloeta Ladd A.M., Arias Vasquez A., Sayed-Tabatabaei F.A., et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005, 14:2143-2146.
25. Sierra Diaz E., Sanchez Corona J., Rosales Gomez R.C., et al. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer. J Renin Angiotensin Aldosterone Syst 2009, 10:241-246.
26. Yigit B., Bozkurt N., Narter F., et al. Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastasis. Anticancer Res 2007, 27:933-936.
27. Medeiros R., Vasconcelos A., Costa S., et al. Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 2004, 202:330-335.
28. Vairaktaris E., Yapijakis C., Tsigris C., et al. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol 2007, 46:1097-1102.
29. Vairaktaris E., Serefoglou Z., Avgoustidis D., et al. Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol 2009, 45:247-253.
30. Usmani B.A., Janeczko M., Shen R., et al. Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer. Br J Cancer 2000, 82:550-552.
31. Cheon K.T., Choi K.H., Lee H.B., et al. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 2000, 178:351-360.
32. Yaren A., Oztop I., Turgut S., et al. Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer. Exp Biol Med (Maywood) 2008, 233:32-37.
33. Sugimoto M., Furuta T., Shirai N., et al. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev 2006, 15:1929-1934.
34. Rocken C., Rohl F.W., Diebler E., et al. The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol Biomarkers Prev 2007, 16:1206-1212.
35. Rocken C., Lendeckel U., Dierkes J., et al. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 2005, 11:2526-2530.
36. Ebert M.P., Lendeckel U., Westphal S., et al. The angiotensin I-converting enzyme gene insertion/deletion polymorphism is linked to early gastric cancer. Cancer Epidemiol Biomarkers Prev 2005, 14:2987-2989.
37. Goto Y., Ando T., Nishio K., et al. The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis. Asian Pac J Cancer Prev 2005, 6:464-467.
38. Toma M., Cimponeriu D., Apostol P., et al. Lack of association between ACE ID polymorphism and colorectal cancer in Romanian patients. Chirurgia (Bucur) 2009, 104:553-556.
39. van der Knaap R., Siemes C., Coebergh J.W., et al. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer 2008, 112:748-757.
40. Rocken C., Neumann K., Carl-McGrath S., et al. The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients. Neoplasia 2007, 9:716-722.
41. Nikiteas N., Tsigris C., Chatzitheofylaktou A., et al. No association with risk for colorectal cancer of the insertion/deletion polymorphism which affects levels of angiotensin-converting enzyme. In Vivo 2007, 21:1065-1068.
42. Sameer A., Nissar S., Bashir S., et al. ACE polymorphism in colorectal cancer patients of Kashmiri population-a short report. Open Colorectal Cancer J 2011, 4:1-5.
43. Ruggenenti P., Perna A., Zoccali C., et al. Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen). J Am Soc Nephrol 2000, 11:88-96.
44. Lee Y.J., Tsai J.C. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002, 25:1002-1008.
45. Yang J.K., Gong Y.Y., Xie L., et al. Lack of genetic association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and longevity in a Han Chinese population. J Renin Angiotensin Aldosterone Syst 2009, 10:115-118.
46. Daimon M., Oizumi T., Saitoh T., et al. The D allele of the angiotensin-converting enzyme insertion/deletion (I/D) polymorphism is a risk factor for type 2 diabetes in a population-based Japanese sample. Endocr J 2003, 50:393-398.
47. Yan C., Zhan J., Feng W. Gene polymorphisms of angiotensin II type 1 receptor and angiotensin-converting enzyme in two ethnic groups living in Zhejiang Province, China. J Renin Angiotensin Aldosterone Syst 2005, 6:132-137.
48. Blanche H., Cabanne L., Sahbatou M., et al. A study of French centenarians: are ACE and APOE associated with longevity?. C R Acad Sci III 2001, 324:129-135.
49. Galinsky D., Tysoe C., Brayne C.E., et al. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 1997, 129:177-183.
50. Panza F., Solfrizzi V., D'Introno A., et al. Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe. Exp Gerontol 2003, 38:1015-1020.
51. Suzuki Y., Ruiz-Ortega M., Lorenzo O., et al. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003, 35:881-900.